February 12, 2020
As per the report titled ‘Intragastric Balloon Market Size By Product (Single Intragastric Balloon, Dual Intragastric Balloon, Triple Intragastric Balloon), By Filling Material (Saline-filled, Gas-filled), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, India, Japan, Australia, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, UAE, Egypt), Application Potential, Competitive Market Share & Forecast, 2019 - 2025’ available with Market Study Report LLC, the global intragastric balloon market is projected to exceed USD 85 million by the year 2025.
Rising prevalence of obesity is the primary driving factor for intragastric balloon market. Increasing adoption of non-surgical and non-invasive treatment procedures will fuel the market growth during the analysis period. Administration of intragastric balloon does not require incisions. This factor coupled with the complications linked with surgical procedures is augmenting the demand for intragastric balloon treatment.
Based on the product type, dual intragastric balloon market segment is presumed to grow with a CAGR of 33.7% during the forecast period. Dual intragastric balloons offer reduced obstruction/migration risk and improved patient comfort as compared to single intragastric balloon, thereby, encouraging patient inclination towards the former.
In terms of the filling material used, gas-filled intragastric balloons segment held 36% market share in 2018 and is expected is show considerable growth in the coming years. The procedure effectively reduces the body weight by 7% within a period of 6 months. Gas-filled intragastric balloons prevent spontaneous deflations and enhance patient compliance at removal.
Speaking of the end-use spectrum, intragastric balloon market from clinics segment accounted for USD 7.8 million in 2018 and will foresee substantial growth over the predicted timeline. The segment growth can be accredited to growing affordability of medical services in conjunction with increasing patient base. In addition, introduction of advanced intragastric balloon will positively impact the market growth in the coming years.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/289514/
Considering the geographical outlook, France intragastric balloon market was worth USD 3.1 million in 2018, on account of increasing demand for weight loss treatments. Surging number of individuals suffering from obesity in the region will augment the business landscape across France.
Prominent players of intragastric balloon market include Obalon Therapeutics, Allurion Technologies, Silimed, ReShape Medical, Districlass Medical, Lexel, Apollo Endosurgery, Spatz, Helioscopie Medical Implants, and Medsil.
Frequently Asked Questions (FAQ) :